Evidence map›Paper›PMID 37463216›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

Engineering activatable promoters for scalable and multi-input CRISPRa/i circuits.

Diego Alba Burbano, Ryan A L Cardiff, Benjamin I Tickman, Cholpisit Kiattisewee, Cassandra J Maranas, Jesse G Zalatan, James M Carothers

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Fine-Tuning Gene Expression in Bacteria by Synthetic Promoters.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Diego Alba BurbanoDepartment of Chemical Engineering, University of Washington, Seattle, WA 98195.ORCID 0000-0002-8476-1506
Ryan A L CardiffCenter for Synthetic Biology, University of Washington, Seattle, WA 98195.ORCID 0009-0001-0530-9010
Benjamin I TickmanCenter for Synthetic Biology, University of Washington, Seattle, WA 98195.
Cholpisit KiattiseweeCenter for Synthetic Biology, University of Washington, Seattle, WA 98195.ORCID 0000-0002-6351-7352
Cassandra J MaranasCenter for Synthetic Biology, University of Washington, Seattle, WA 98195.ORCID 0000-0003-0969-5489
Jesse G ZalatanCenter for Synthetic Biology, University of Washington, Seattle, WA 98195.ORCID 0000-0002-1458-0654
James M CarothersDepartment of Chemical Engineering, University of Washington, Seattle, WA 98195.ORCID 0000-0001-6728-7833
University of Washington · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dynamic, multi-input gene regulatory networks (GRNs) are ubiquitous in nature. Multilayer CRISPR-based genetic circuits hold great promise for building GRNs akin to those found in naturally occurring biological systems. We develop an approach for creating high-performing activatable promoters that can be assembled into deep, wide, and multi-input CRISPR-activation and -interference (CRISPRa/i) GRNs. By integrating sequence-based design and in vivo screening, we engineer activatable promoters that achieve up to 1,000-fold dynamic range in an

Indexed as

Escherichia coliEscherichia coli ProteinsCRISPR-Cas SystemsGene Regulatory NetworksPromoter Regions, GeneticEscherichia coli Proteinsactivatable promoter engineeringcell-freeCRISPR activationgene regulatory networksgenetic circuits

Identifiers

PMID37463216
PMCPMC10374173
OpenAlexW4384662863

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.